{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:20:01Z","timestamp":1771917601837,"version":"3.50.1"},"reference-count":210,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.drugalcdep.2011.03.006","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T15:56:42Z","timestamp":1303747002000},"page":"100-110","source":"Crossref","is-referenced-by-count":45,"title":["Potential role of safer injection facilities in reducing HIV and Hepatitis C infections and overdose mortality in the United States"],"prefix":"10.1016","volume":"118","author":[{"given":"Salaam","family":"Semaan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Worrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Stolp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney","family":"Baack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1057\/jphp.2009.52","article-title":"Understanding the origins of anger, contempt, and disgust in public health policy disputes: applying moral psychology to harm reduction debates","volume":"31","author":"Alderman","year":"2010","journal-title":"J. Pub. Health Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugpo.2009.03.004","article-title":"A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility","volume":"21","author":"Andresen","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.drugalcdep.2010.08.003","article-title":"Cochrane systematic reviews in the field of addiction: what's there and what should be","volume":"113","author":"Amato","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11524-010-9442-8","article-title":"Primary and secondary analysis of local elected officials\u2019 decisions to support or oppose pharmacy sale of syringes in California","volume":"87","author":"Backes","year":"2010","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s15010-004-3106-0","article-title":"Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies","volume":"32","author":"Bassetti","year":"2004","journal-title":"Infection"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0030","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s11524-009-9356-5","article-title":"Who purchases nonprescription syringes? Characterizing customers of the expanded syringe access program (ESAP)","volume":"86","author":"Battles","year":"2009","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0035","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1503\/cmaj.080808","article-title":"The cost-effectiveness of Vancouver's supervised injection facility","volume":"179","author":"Bayoumi","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2105\/AJPH.2006.103747","article-title":"The law (and politics) of safe injection facilities in the United States","volume":"98","author":"Beletsky","year":"2008","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0045","series-title":"A Field Guide to Good Decisions: Values in Action","author":"Bennett","year":"2006"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2011.03.006_bib0050","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.2105\/AJPH.2005.077305","article-title":"Evidence and effectiveness in decision making for quarantine","volume":"97","author":"Bensimon","year":"2007","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.PHH.0000324566.72533.0b","article-title":"Mitigating pandemic influenza: the ethics of implementing a school closure policy","volume":"14","author":"Berkman","year":"2008","journal-title":"J. Public Health Manage. Pract."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0060","series-title":"Law in Public Health Practice","first-page":"43","article-title":"Ethics and the practice of public health","author":"Bernheim","year":"2006"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0065","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1086\/313703","article-title":"High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco","volume":"30","author":"Binswanger","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0070","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1360-0443.2010.02942.x","article-title":"Commentary on Palmateer et al. (2010): next steps in the global research agenda on syringe access for injection drug users","volume":"105","author":"Bluthenthal","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.12.035","article-title":"High syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients","volume":"89","author":"Bluthenthal","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugalcdep.2010.07.008","article-title":"Policing and risk of overdose mortality in urban neighborhoods","volume":"113","author":"Bohnert","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0085","article-title":"Alternatives to randomization in the evaluation of public health interventions: design challenges and solutions","author":"Bonell","year":"2010","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0090","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.socscimed.2006.03.026","article-title":"Should structural interventions be evaluated using RCTs? The case of HIV prevention","author":"Bonell","year":"2006","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugalcdep.2010.04.003","article-title":"Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago","volume":"111","author":"Boodram","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/003335490812300102","article-title":"Ethical obligations of physicians participating in public health quarantine and isolation measures","volume":"123","author":"Bostick","year":"2008","journal-title":"Public Health Rep."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0105","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1360-0443.2008.02474.x","article-title":"Use of supervised injection facilities and injection risk behaviors among young drug injectors","volume":"104","author":"Bravo","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/002204260203200113","article-title":"Safer injection facilities in North America: their place in public policy and health initiatives","volume":"31","author":"Broadhead","year":"2002","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/002204260303300301","article-title":"Safer injection facilities: obstacles, proposals, policies, and program evaluations","volume":"33","author":"Broadhead","year":"2003","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/002204260303300311","article-title":"Safer injection sites in New York City: a utilization survey of injection drug users","volume":"33","author":"Broadhead","year":"2003","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0125","first-page":"59","article-title":"Amsterdam's drug policy and its implications for controlling needle sharing","volume":"vol. 80","author":"Buning","year":"1998"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0130","first-page":"1088","article-title":"Federalism, policy learning, and local innovation in public health: the case of the supervised injection facility","volume":"53","author":"Burris","year":"2008","journal-title":"St. Louis Univ. Law J."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0135","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2105\/AJPH.86.8_Pt_1.1161","article-title":"The legal strategies used in operating syringe exchange programs in the United States","volume":"86","author":"Burris","year":"1996","journal-title":"Am. J. Public Health"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2011.03.006_bib0140","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1331\/1086-5802.42.0.S13.Burris","article-title":"The legality of selling or giving syringes to injection drug users","volume":"42","author":"Burris","year":"2002","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0145","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMra023160","article-title":"Drug addiction","volume":"349","author":"Cami","year":"2003","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0150","first-page":"329","article-title":"HIV-associated behaviors among injecting-drug users\u201423 cities, United States, May 2005\u2013February 2006","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0155","first-page":"300","article-title":"Unintentional drug poisoning in the United States (Announcements: release of issue brief)","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2105\/AJPH.80.2.150","article-title":"HIV seropositivity of needles from shooting galleries in South Florida","volume":"80","author":"Chitwood","year":"1990","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugpo.2007.11.020","article-title":"Virtue ethics as an alternative to deontological and consequential reasoning in the harm reduction debate","volume":"19","author":"Christie","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0955-3959(03)00130-0","article-title":"A comparison of the new federal guidelines regulating supervised injection research site in Canada and the tri-council policy statement on ethical conduct for research involving human subjects","volume":"15","author":"Christie","year":"2004","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0175","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1086\/381095","article-title":"Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City","volume":"38","author":"Coffin","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drugpo.2005.07.005","article-title":"As strong as the weakest pillar: harm reduction, law enforcement and human rights","volume":"17","author":"Cohen","year":"2006","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0185","unstructured":"Congress of the United States of America (111th Congress). Consolidated appropriations act: Public law 111-117 (Division D, Title V, Section 505). http:\/\/frwebgate.access.gpo.gov\/cgi-bin\/getdoc.cgi?dbname=111_cong_bills&docid=f:h3288enr.txt.pdf, 2010."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11524-010-9483-z","article-title":"Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007","volume":"87","author":"Cooper","year":"2010","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0195","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.socscimed.2004.12.030","article-title":"The impact of a police drug crackdown on drug injectors\u2019 ability to practice harm reduction: a qualitative study","volume":"61","author":"Cooper","year":"2005","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0200","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11524-009-9399-7","article-title":"Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial\/ethnic composition and need","volume":"86","author":"Cooper","year":"2009","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0205","first-page":"3","article-title":"A critical evaluation of the effects of safe injection facilities","volume":"1","author":"Davies","year":"2007","journal-title":"J. Global Drug Policy Pract."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2010.07.023","article-title":"Injection drug use cessation and use of North America's first medically supervised safer injecting facility","volume":"113","author":"DeBeck","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1747-597X-3-11","article-title":"Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility","volume":"3","author":"DeBeck","year":"2008","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0220","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0225","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0230","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2010.07.026","article-title":"Mortality among cocaine users: a systematic review of cohort studies","volume":"113","author":"Degenhardt","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jama.271.2.121","article-title":"Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992","volume":"271","author":"Des Jarlais","year":"1994","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2011.03.006_bib0240","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.2105\/AJPH.2008.159327","article-title":"Persistence and change in disparities in HIV among injecting drug users in New York City after large-scale syringe exchange","volume":"99","author":"Des Jarlais","year":"2009","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0245","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0140-6736(10)60314-5","article-title":"Increasing HIV prevention and care for injecting drug users","volume":"375","author":"Des Jarlais","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0250","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1503\/cmaj.081678","article-title":"Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics","volume":"179","author":"Des Jarlais","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0255","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2009.12.028","article-title":"HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors","volume":"109","author":"Des Jarlais","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0260","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/COH.0b013e32832bbc6f","article-title":"HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised injection facilities","volume":"4","author":"Des Jarlais","year":"2009","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2011.03.006_bib0265","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s10461-007-9227-6","article-title":"Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs","volume":"11","author":"Des Jarlais","year":"2007","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0270","series-title":"Oxford Textbook of Public Health: The Practice of Public Health","first-page":"1303","article-title":"Drug abuse","author":"Des Jarlais","year":"2009"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0275","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1360-0443.2008.02465.x","article-title":"Doing harm reduction better: syringe exchange in the United States","volume":"104","author":"Des Jarlais","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0280","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/PSY.0b013e3181772157","article-title":"HIV prevention for injecting drug users: the first 25 years and counting","volume":"70","author":"Des Jarlais","year":"2008","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/jech.2008.079301","article-title":"HIV prevention and psychoactive drug use: a research agenda","volume":"63","author":"Des Jarlais","year":"2009","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0290","series-title":"HIV\/AIDS in the Post-HAART Era: Manifestations, Treatment, and Epidemiology","first-page":"753","article-title":"At 30 years: HIV\/AIDS and other STDs among persons who use psychoactive drugs","author":"Des Jarlais","year":"2011"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0295","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2105\/AJPH.2004.058933","article-title":"Ethical goals of community consultation in research","volume":"95","author":"Dickert","year":"2005","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0300","first-page":"1399","article-title":"Drug consumption facilities in Europe and the establishment of supervised injection centers in Australia","volume":"175","author":"Dolan","year":"2000","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0305","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1503\/cmaj.100032","article-title":"Vancouver's supervised injection facility challenges Canada's drug laws","volume":"182","author":"Dooling","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0310","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(10)61026-4","article-title":"HIV and women who use drugs: double neglect, double risk","volume":"376","author":"El-Bassel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0315","first-page":"7","article-title":"Establishing safe injection facilities in Canada: legal and ethical issues","volume":"6","author":"Elliot","year":"2002","journal-title":"Can. HIV\/AIDS Policy Law Rev."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0320","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.socscimed.2008.05.012","article-title":"Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility","volume":"7","author":"Fairbairn","year":"2008","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0325","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1477-7517-5-32","article-title":"The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility","volume":"5","author":"Fast","year":"2008","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0330","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.drugpo.2004.04.002","article-title":"Drug use, risk and urban order: examining supervised injection sites (SISs) as governmentality","volume":"15","author":"Fischer","year":"2004","journal-title":"Int. J. Drug Policy"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2011.03.006_bib0335","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1080\/1462220021000032861","article-title":"Tobacco harm reduction: a call to address the ethical dilemmas","volume":"4","author":"Fox","year":"2002","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0340","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.aids.0000196176.65551.a3","article-title":"Relationship of deterrence and law enforcement to drug-related harms among drug injectors in U.S. metropolitan cities","volume":"20","author":"Friedman","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0345","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2105\/AJPH.2010.191759","article-title":"Drug arrests and injection drug deterrence","volume":"101","author":"Friedman","year":"2011","journal-title":"Am. J. Public Health"},{"issue":"8","key":"10.1016\/j.drugalcdep.2011.03.006_bib0350","first-page":"777","article-title":"Safer injecting facilities in Vancouver: considering issues beyond potential use","volume":"169","author":"Fry","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0355","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1360-0443.2006.01386.x","article-title":"The place of supervised injecting facilities within harm reduction: evidence, ethics, and policy","volume":"101","author":"Fry","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0360","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2105\/AJPH.2005.069591","article-title":"Multilevel community-based intervention to increase access to sterile syringes across injection drug users through pharmacy sales in New York City","volume":"97","author":"Fuller","year":"2007","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0365","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11524-010-9463-3","article-title":"Three years after legalization of non-prescription syringe sales in California: where are we now?","volume":"87","author":"Garfein","year":"2010","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0370","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0375","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drugalcdep.2010.03.022","article-title":"Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies","volume":"111","author":"Green","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0380","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14659890500114359","article-title":"A \u201ccomponents\u201d model of addiction within a biopsychosocial framework","volume":"10","author":"Griffiths","year":"2005","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0385","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2105\/AJPH.92.5.698","article-title":"Ethics, human rights, and public health","volume":"92","author":"Gruskin","year":"2002","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0390","first-page":"1488","article-title":"Syringe exchange programs\u2014United States, 2008","volume":"59","author":"Guardino","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0395","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.drugpo.2005.09.003","article-title":"The evolution of the four pillars: acknowledging the harms of drug prohibition","volume":"17","author":"Haden","year":"2006","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0400","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0955-3959(02)00125-1","article-title":"Supervised injection rooms\u2014prospects and limitations","volume":"13","author":"Hagan","year":"2002","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0405","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.drugpo.2007.01.016","article-title":"HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection","volume":"18","author":"Hagan","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0410","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/aje\/kwn237","article-title":"Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place","volume":"168","author":"Hagan","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0415","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jama.300.5.520","article-title":"Estimation of HIV incidence in the United States","volume":"300","author":"Hall","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugpo.2007.11.006","article-title":"Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver","volume":"19","author":"Hathaway","year":"2008","journal-title":"Int. J. Drug Policy"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2011.03.006_bib0425","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/00042560-200207011-00002","article-title":"Theoretical issues in the synthesis of HIV prevention research","volume":"30","author":"Hedges","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0430","unstructured":"Hedrich, D., 2004. European report on drug consumption rooms. European Monitoring Centre for Drugs and Drug Addiction. http:\/\/emcdda.europa.eu\/ (accessed Dec 18, 2010), pp. 1\u201396."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0435","series-title":"Harm Reduction: Evidence, Impacts and Challenges","first-page":"305","article-title":"Drug consumption facilities in Europe and beyond","author":"Hedrich","year":"2010"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0440","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugpo.2005.10.005","article-title":"If enforcement is not working, what are the alternatives?","volume":"17","author":"Heed","year":"2006","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2005.06.008","article-title":"Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement","volume":"81","author":"Heinzerling","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-6-1","article-title":"The syringe gap: an assessment of sterile syringe need and acquisition among syringe exchange program participants in New York City","volume":"6","author":"Heller","year":"2009","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0455","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0460","series-title":"Health and Social Justice: Politics, Ideology and Inequity in the Distribution of Disease","first-page":"1","article-title":"The politics of health inequities: contested terrain","author":"Hofrichter","year":"2003"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0465","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1360-0443.1999.9422216.x","article-title":"Quantification of mortality from the regular use of illicit opiates","volume":"94","author":"Hulse","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0470","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1521\/aeap.17.3.170.62900","article-title":"Drug use and HIV risk practices of secondary and primary needle exchange users","volume":"17","author":"Huo","year":"2005","journal-title":"AIDS Educ. Prev."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0475","first-page":"606","article-title":"Integrating ethics, health policy and health systems in low- and middle-income countries: case studies from Malaysia and Pakistan","volume":"86","author":"Hyder","year":"2008","journal-title":"Bull. WHO"},{"issue":"2","key":"10.1016\/j.drugalcdep.2011.03.006_bib0480","first-page":"e99","article-title":"Science and ideology","volume":"1","author":"Hwang","year":"2007","journal-title":"Open Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0485","unstructured":"Institute of Medicine, 2010. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Institute of Medicine, Washington, DC. http:\/\/www.nap.edu\/catalog\/12793.html (accessed 1\/21\/2011)."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0490","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugpo.2006.12.002","article-title":"Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction","volume":"18","author":"Irwin","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0495","unstructured":"Jenness, S., 2008. Continuing HIV risk in NYC IDU: the association of syringe source and syringe sharing. NHBS-IDU2 Principal Investigators Meeting, Atlanta, GA."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0500","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/10826084.2011.521467","article-title":"Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing","volume":"46","author":"Jenness","year":"2011","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0505","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(10)60830-6","article-title":"People who use drugs, HIV, and human rights","volume":"376","author":"Jurgens","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0510","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.2105\/AJPH.91.11.1776","article-title":"An ethics framework for public health","volume":"91","author":"Kass","year":"2001","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0515","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11904-007-0023-8","article-title":"The role of safer injection facilities in the response to HIV\/AIDS among injection drug users","volume":"4","author":"Kerr","year":"2007","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0520","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0140-6736(08)61138-1","article-title":"Supervised injecting facilities: time for scale-up?","volume":"372","author":"Kerr","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0525","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugpo.2006.12.008","article-title":"A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility","volume":"18","author":"Kerr","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0530","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.drugpo.2006.05.008","article-title":"Drug-related overdoses within a medically supervised safer injection facility","volume":"17","author":"Kerr","year":"2006","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0535","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(05)66475-6","article-title":"Safer injection facility use and syringe sharing in injection drug users","volume":"366","author":"Kerr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0540","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2105\/AJPH.2006.086256","article-title":"Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility","volume":"97","author":"Kerr","year":"2007","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0545","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/002204260303300303","article-title":"Responding to an explosive HIV epidemic driven by frequent cocaine injection: Is there a role for safe injecting facilities?","volume":"33","author":"Kerr","year":"2003","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0550","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/095952301000116951","article-title":"Drug consumption facilities: an update since 2000","volume":"2","author":"Kimber","year":"2003","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0555","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/002204260303300306","article-title":"The Sydney medically supervised injecting centre: client characteristics and predictors of frequent attendance during the first 12 months of operation","volume":"33","author":"Kimber","year":"2003","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0560","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/002204260303300312","article-title":"Shooting gallery users and HIV risk","volume":"33","author":"Klein","year":"2003","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0565","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.drugalcdep.2010.02.009","article-title":"Acceptability of a safer injection facility among injection drug users in San Francisco","volume":"110","author":"Kral","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.drugalcdep.2011.03.006_bib0575","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2105\/AJPH.2007.113415","article-title":"A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C","volume":"98","author":"Latka","year":"2008","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0570","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3109\/10826089209068763","article-title":"Needle-cleaning practices among intravenous drug users who share injection equipment in Baltimore, Marlyand","volume":"27","author":"Latkin","year":"1992","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0580","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1007\/s10461-010-9804-y","article-title":"A dynamic social systems model for considering structural factors in HIV prevention and detection","volume":"14","author":"Latkin","year":"2010","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0585","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2003.09.005","article-title":"Social network correlates of self-reported non-fatal overdose","volume":"73","author":"Latkin","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0590","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.socscimed.2008.10.011","article-title":"A meta-analysis of the hepatitis C virus distribution in diverse racial\/ethnic drug injector groups","volume":"68","author":"Lelutiu-Weinberger","year":"2009","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0595","first-page":"16","article-title":"Gaining INSITE: harm reduction in nursing practice","volume":"105","author":"Lightfoot","year":"2009","journal-title":"Can. Nurse"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0600","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/1471-2458-8-405","article-title":"Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study","volume":"8","author":"Lloyd-Smith","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0605","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/10826080600669041","article-title":"Secondary syringe exchange among users of 23 California syringe exchange programs","volume":"41","author":"Lorvick","year":"2006","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0610","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0140-6736(96)05439-6","article-title":"An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA","volume":"349","author":"Lurie","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0615","unstructured":"Maher, S.A., Maher, S.A., Kaldor, J., 2005. Sydney medically supervised injecting centre: interim evaluation. National centre in HIV epidemiology and clinical research, Report no. 1., Sydney, pp. 1\u201331."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0620","first-page":"2","article-title":"A critique of Canada's Insite injection site and its parent philosophy: implications and recommendations for policy planning","volume":"1","author":"Mangham","year":"2007","journal-title":"J. Global Drug Policy Pract."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0625","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.drugalcdep.2010.01.022","article-title":"Public injecting and HIV risk behavior among street-involved youth","volume":"110","author":"Marshall","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2011.03.006_bib0630","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/QAI.0b013e3181f9c203","article-title":"Toward a comprehensive approach to HIV prevention for people who use drugs","volume":"55","author":"Marshall","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0635","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11524-006-9139-1","article-title":"The impact of legalizing syringe exchange programs on arrests among injection drug users in California","volume":"84","author":"Martinez","year":"2007","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0640","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/10826080903080631","article-title":"Organizational issues in the implementation of a hospital-based syringe exchange program","volume":"45","author":"Masson","year":"2010","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0645","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"for the 2009 reference group to the UN on HIV and injecting drug use HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0650","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0655","first-page":"1164","article-title":"Syringe exchange programs\u2014United States, 2005","volume":"56","author":"McKnight","year":"2007","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0660","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7517-3-8","article-title":"Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey","volume":"3","author":"McNeely","year":"2006","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sste.2010.10.001","article-title":"Spatio-temporal epidemiology: principles and opportunities","volume":"2","author":"Meliker","year":"2011","journal-title":"Spat. Spattemporal Epidemiol."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0670","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00952990802122457","article-title":"Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility","volume":"34","author":"Milloy","year":"2008","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0680","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0140-6736(10)60936-1","article-title":"Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study","volume":"376","author":"Montaner","year":"2010","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2011.03.006_bib0685","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/QAI.0b013e3181f9c1f0","article-title":"Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes","volume":"55","author":"Montaner","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0690","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/320879","article-title":"Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study","volume":"33","author":"Murphy","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0695","unstructured":"Office of Applied Studies and Substance Abuse and Mental Health Services Administration, 2007. The NSDUH report: Demographic and geographic variations in injection drug use. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0700","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1360-0443.2009.02888.x","article-title":"Evidence of the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews","volume":"105","author":"Palmateer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0705","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2105\/AJPH.2007.127027","article-title":"Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches","volume":"98","author":"Pals","year":"2008","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0710","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugpo.2008.09.002","article-title":"Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico","volume":"20","author":"Philbin","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0715","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2007.11.005","article-title":"Harm reduction through a social justice lens","volume":"19","author":"Pauly","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0720","first-page":"19","article-title":"The ethical, legal and social context of harm reduction","volume":"10","author":"Pauly","year":"2007","journal-title":"Can. Nurse"},{"issue":"5","key":"10.1016\/j.drugalcdep.2011.03.006_bib0725","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.addbeh.2006.07.013","article-title":"Injection drug users\u2019 perceptions regarding use of a medically supervised safer injecting facility","volume":"32","author":"Petrar","year":"2007","journal-title":"Addict. Behav."},{"issue":"8","key":"10.1016\/j.drugalcdep.2011.03.006_bib0730","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1360-0443.2010.02977.x","article-title":"Is Vancouver Canada's supervised injection facility cost-saving?","volume":"105","author":"Pinkerton","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0735","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/phe\/php013","article-title":"Inclusion of adolescent women in microbicide trials: a public health imperative","volume":"3","author":"Pomfret","year":"2010","journal-title":"Public Health Ethics"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0740","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.qai.0000152395.82885.c0","article-title":"Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York state expanded syringe access demonstration project","volume":"39","author":"Pouget","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0745","series-title":"Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic of Liver Disease","author":"Pyenson","year":"2009"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0750","series-title":"A Theory of Justice","author":"Rawls","year":"1971"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0755","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jsat.2007.11.003","article-title":"Methamphetamine dependence and human immunodeficiency virus risk behavior","volume":"35","author":"Rawson","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0760","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1360-0443.2006.01556.x","article-title":"Public injecting and the need for safer environment interventions in the reduction of drug-related harm","volume":"101","author":"Rhodes","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0765","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/00952990802146308","article-title":"Employment among users of a medically supervised safer injection facility","volume":"34","author":"Richardson","year":"2008","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0770","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s11524-010-9468-y","article-title":"Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users","volume":"87","author":"Riley","year":"2010","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0775","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/09595230600944529","article-title":"A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs","volume":"25","author":"Ritter","year":"2006","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0780","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2009.08.007","article-title":"Environmental conditions, political economy, and rates of injection drug use in large US metropolitan areas 1992\u20132002","volume":"106","author":"Roberts","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0785","unstructured":"Roy, D. J., 2000. Injection drug use and HIV\/AIDS: an ethics commentary on priority issues, Health Canada, www.aidslaw.ca\/publications (accessed 1\/18\/2011)."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0790","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1360-0443.2009.02837.x","article-title":"The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia","volume":"105","author":"Salmon","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0795","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/01.mlr.0000228021.89490.2a","article-title":"The lifetime cost of current human immunodeficiency virus care in the United States","volume":"44","author":"Schackman","year":"2006","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0800","series-title":"Rights Based Approaches to Public Health","first-page":"201","article-title":"Human rights and HIV prevention among drug users","author":"Semaan","year":"2010"},{"issue":"1","key":"10.1016\/j.drugalcdep.2011.03.006_bib0805","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-3-1","article-title":"Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users","volume":"3","author":"Shannon","year":"2006","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0810","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.drugalcdep.2006.10.006","article-title":"Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city","volume":"88","author":"Sherman","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0815","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/aje\/kwm189","article-title":"Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of undergoing principles","volume":"166","author":"Shrier","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0820","article-title":"IDU perspectives on the design and operation of North America's first medically supervised injection facility","author":"Small","year":"2010","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0825","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1465-3362.2009.00025.x","article-title":"Access to health and social services for IDU: the impact of a medically supervised injection facility","volume":"28","author":"Small","year":"2009","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0830","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.drugalcdep.2008.05.014","article-title":"Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study","volume":"98","author":"Small","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0835","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugpo.2005.12.008","article-title":"Ethical reflections emerging during the activity of a low threshold facility with supervised drug consumption room in Geneva, Switzerland","volume":"17","author":"Solai","year":"2006","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0840","first-page":"894","article-title":"Risk factor for elevated HIV incidence rates among female injection drug users in Vancouver","volume":"166","author":"Spittal","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0845","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2004.02.002","article-title":"Correlates of Hepatitis C virus infection in homeless men: a latent variable approach","volume":"75","author":"Stein","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0850","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1037\/0893-164X.22.3.410","article-title":"Effects of psychosocial and situational variables on substance abuse among homeless adults","volume":"22","author":"Stein","year":"2008","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0855","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1557988307307862","article-title":"Situational, psychosocial, and physical health\u2014related correlates of HIV\/AIDS risk behaviors in homeless men","volume":"3","author":"Stein","year":"2009","journal-title":"Am. J. Men's Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0860","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/pubmed\/fdl090","article-title":"Changes in injecting practices associated with the use of a medically supervised safer injection facility","volume":"29","author":"Stoltz","year":"2007","journal-title":"J. Public Health (Oxf.)"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0865","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11524-006-9122-x","article-title":"Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel","volume":"84","author":"Stopka","year":"2007","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0870","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/COH.0b013e328343ac05","article-title":"HIV models to inform health policy","volume":"6","author":"Stover","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0875","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1360-0443.2007.01859.x","article-title":"A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery","volume":"102","author":"Strathdee","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0880","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1360-0443.2010.02917.x","article-title":"Commentary on Salmon et al. (2010): the case for safer inhalation facilities-waiting to inhale","volume":"105","author":"Strathdee","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0885","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jurban\/jtg127","article-title":"Type and location of injection drug-use related soft tissue infections predict hospitalization","volume":"80","author":"Takahashi","year":"2003","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0890","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.healthplace.2006.05.004","article-title":"Placing the dynamics of syringe exchange programs in the United States","volume":"13","author":"Tempalski","year":"2007","journal-title":"Health Place"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2105\/AJPH.2005.065961","article-title":"Social and political factors predicting the presence of syringe exchange programs in 96 metropolitan areas","volume":"97","author":"Tempalski","year":"2007","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0900","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2008.02.002","article-title":"Drug scapes and the role of place and space in injection drug use-related HIV risk environments","volume":"20","author":"Tempalski","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0905","unstructured":"The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978. The Belmont report: ethical principles and guidelines for the protection of human subjects of research. U.S. Government Printing Office, DHEW Publication No. (OS 78-0012), Washington, DC."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0910","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s10461-010-9670-7","article-title":"Social-level correlates of shooting gallery attendance: a focus on networks and norms","volume":"14","author":"Tobin","year":"2010","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0915","unstructured":"U.S.Constitution, 2006a. A. 2. 8. Penalties for simple possession, http:\/\/www.justice.gov\/dea\/pubs\/csa.html, 8-24-2010a."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0920","unstructured":"U.S.Constitution, 2006b. A. 2. 8. Crack House Statute, http:\/\/www.justice.gov\/dea\/pubs\/csa.html, 8-24-2010b."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0925","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/09540261.2010.482097","article-title":"Ethical perspectives in caring for people living with addictions: the European experience","volume":"22","author":"Uchtenhagen","year":"2010","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0930","unstructured":"United States General Accounting Office, 1993. Needle exchange programs: Research suggests promise as an AIDS prevention strategy. United States General Accounting Office, GAO\/HRD-93-60, Washington, D.C."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0935","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/002204260303300305","article-title":"The Sydney medically supervised injecting centre: a clinical model","volume":"33","author":"van Beek","year":"2003","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0940","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1747-597X-4-10","article-title":"Nowhere to go: how stigma limits the options of female drug users after release from jail","volume":"4","author":"van Olphen","year":"2009","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0945","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1186\/1472-6939-5-2","article-title":"Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives","volume":"5","author":"Verma","year":"2004","journal-title":"BMC Med. Ethics"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0950","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.qai.0000219788.73539.47","article-title":"Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users","volume":"42","author":"Vickerman","year":"2006","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0955","series-title":"Increase in fatal poisonings involving opioid analgesics in the United States, 1996-2006","author":"Warner","year":"2009"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0960","unstructured":"Wenger, L.D., Arreola, S., Kral, A.H., 2011a. The prospect of implementing a safer injecting facility in San Francisco: perspectives of community stakeholders. Int. J. Drug Policy, doi:10.1016\/j.drugpo.2011.01.011."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0965","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2105\/AJPH.2009.179531","article-title":"Syringe disposal among injection drug users in San Francisco","volume":"101","author":"Wenger","year":"2011","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0970","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2105\/AJPH.2007.124446","article-title":"Alternatives to the randomized controlled trial","volume":"98","author":"West","year":"2008","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0975","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2105\/AJPH.2008.141846","article-title":"Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users","volume":"99","author":"Wiessing","year":"2009","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0980","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2105\/AJPH.2008.158337","article-title":"Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis","volume":"100","author":"Williams","year":"2010","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0985","first-page":"46","article-title":"Needle exchange and bleach distribution programmes: the Australian experience","volume":"6","author":"Wodak","year":"1995","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0990","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/002204260303300307","article-title":"Drug consumption facilities in the Netherlands","volume":"33","author":"Wolfe","year":"2003","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib0995","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00126334-200301010-00002","article-title":"The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users","volume":"32","author":"Wood","year":"2003","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1000","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-1-9","article-title":"Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users","author":"Wood","year":"2004","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(04)01006-0","article-title":"Rationale for evaluating North America's first medically supervised safer-injecting facility","volume":"4","author":"Wood","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1010","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.puhe.2005.05.006","article-title":"Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility","volume":"119","author":"Wood","year":"2005","journal-title":"Public Health"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amepre.2005.04.011","article-title":"Do supervised injecting facilities attract higher-risk injection drug users?","volume":"29","author":"Wood","year":"2005","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.drugpo.2005.07.004","article-title":"Safer injecting education for HIV prevention within a medically supervised injecting facility","volume":"16","author":"Wood","year":"2005","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1025","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1503\/cmaj.060863","article-title":"Summary of findings from the evaluation of a pilot medically supervised safer injecting facility","volume":"175","author":"Wood","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1030","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1056\/NEJMc052939","article-title":"Attendance at supervised injecting facilities and use of detoxification services","volume":"354","author":"Wood","year":"2006","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1035","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1360-0443.2007.01818.x","article-title":"Rate of detoxification service use and its impact among a cohort of supervised injecting facility users","volume":"102","author":"Wood","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugpo.2007.11.001","article-title":"The Canadian government's treatment of the scientific process and evidence: inside the evaluation of North America's first supervised injecting facility","volume":"19","author":"Wood","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2008.01.003","article-title":"Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility","volume":"19","author":"Wood","year":"2008","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1050","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)60455-4","article-title":"The war on drugs: a devastating public-policy disaster","volume":"373","author":"Wood","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2011.03.006_bib1055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/002204260303300308","article-title":"Drug consumption rooms in Hamburg, Germany: evaluation of the effects on harm reduction and the reduction of public nuisance","volume":"33","author":"Zurhold","year":"2003","journal-title":"J. Drug Issues"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611001323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611001323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T05:58:20Z","timestamp":1637560700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871611001323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":210,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0376871611001323"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.03.006","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}